Search

Brian T Wipke

from Lexington, MA
Age ~57
Get Report
Also known as:
Brian K Wipke, Brian Witke
Phone and address:
53 Asbury St, Lexington, MA 02421
(650) 270-8342
Related to:
Keith B Wike, 55Olivia Wipke, 29Keith Wipke, 55
Connected to:
Katie WipperfurthJessica D Wipperman, 28Helen L Wippert, 88Livia D Wippich, 49David Wippman, 69Elizabeth M Wira, 69Ashley Wirasinha, 53Carol R Wirbel, 74Brenda Wire, 50Melody D Wire, 45

Brian Wipke Phones & Addresses

  • 53 Asbury St, Lexington, MA 02421 (650) 270-8342
  • 16 Katahdin Dr, Lexington, MA 02421 (781) 538-4160
  • Belmont, CA
  • 601 Hillsdale Blvd, San Mateo, CA 94403 (650) 458-9959
  • 1501 Chapin Ave, Burlingame, CA 94010
  • San Francisco, CA
  • Saint Louis, MO
  • Seattle, WA
  • Berkeley, CA
  • 201 Harrison St APT 825, San Francisco, CA 94105

Work

Company: Moderna Apr 2019 Position: Director of immunology, new venture labs

Education

School / High School: Washington University 2003

Skills

Pharmacology • Drug Discovery • In Vivo • Assay Development • Biotechnology • Biomarkers • In Vitro • Antibodies • Immunology • Drug Development • Biochemistry • High Throughput Screening • Cell Biology • Cell Culture • Elisa • Cell • Translational Medicine • Neuroscience • Biopharmaceuticals • Monoclonal Antibodies • Protein Chemistry • Animal Models • Immunoassays • Clinical Development • Virology • Flow Cytometry • Neurodegeneration • Translational Research • Tissue Culture • Immunohistochemistry • Inflammation

Industries

Biotechnology

Resumes

Resumes

Brian Wipke Photo 1

Director Of Immunology, New Venture Labs

View page
Location:
53 Asbury St, Lexington, MA 02421
Industry:
Biotechnology
Work:
Moderna
Director of Immunology, New Venture Labs
Biogen Nov 2017 - Mar 2019
Principal Scientist, Acute Neurology
Biogen Apr 2016 - Nov 2017
Principal Scientist, Neuroimmunology
Biogen Jul 2011 - Apr 2016
Principal Scientist, Neurology
Elan Mar 2007 - Jul 2011
Associate Director, Autoimmune Pharmacology
Education:
Washington University 2003
University of Washington 1997
University of Washington - School of Medicine 1991 - 1997
Doctorates, Doctor of Philosophy, Immunology University of California, Berkeley 1985 - 1989
Bachelors, Bachelor of Arts, Genetics
Skills:
Pharmacology
Drug Discovery
In Vivo
Assay Development
Biotechnology
Biomarkers
In Vitro
Antibodies
Immunology
Drug Development
Biochemistry
High Throughput Screening
Cell Biology
Cell Culture
Elisa
Cell
Translational Medicine
Neuroscience
Biopharmaceuticals
Monoclonal Antibodies
Protein Chemistry
Animal Models
Immunoassays
Clinical Development
Virology
Flow Cytometry
Neurodegeneration
Translational Research
Tissue Culture
Immunohistochemistry
Inflammation

Publications

Us Patents

Selective Integrin Inhibitors

View page
US Patent:
20120059029, Mar 8, 2012
Filed:
May 2, 2011
Appl. No.:
13/098538
Inventors:
Anthony Pepio - Carlsbad CA, US
Gordon Francis - San Francisco CA, US
Theodore A. Yednock - Forest Knolls CA, US
Alissa Chackerian - Sunnyvale CA, US
Brian Todd Wipke - Lexington MA, US
Assignee:
Elan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A61K 31/437
A61P 35/00
A61P 29/00
A61P 37/02
US Classification:
514303
Abstract:
This invention provides methods for selectively antagonizing the α4β1 integrin heterodimer in a subject in need thereof, and preferably in a human subject. The methods of the invention utilize conjugates comprising two or more α4β1 small molecule antagonists covalently attached to a biocompatible polymer. These methods of selectively inhibiting α4β1 may be used modulate both normal and pathological biological processes mediated at least in part through α4β1 activity.
Control profile
Brian T Wipke from Lexington, MA, age ~57 Get Report